Ads
related to: tocilizumab prescribing information pdf- Safety & Risk Factor Info
View Metabolic Syndrome Risk Info
For a Psoriasis Treatment Option.
- Clinical Studies
Review Clinical Trial Results for
a Plaque Psoriasis Treatment.
- HCP Dosing Resources
View Treatment Options For Moderate
to Severe Plaque Psoriasis.
- Real-World Data for HCPs
Review Real-World Study Results
For a Psoriasis Treatment Option.
- Biologic MOA for PsO
Learn More About the MOA for this
Plaque Psoriasis Treatment.
- Important HCP Information
See Psoriasis Treatment Options To
Help Your Patients Find Relief.
- Safety & Risk Factor Info
Search results
Results From The WOW.Com Content Network
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...
The FDA prescribing information for canakinumab (Ilaris) includes a warning for potential increased risk of serious infections due to IL-1 blockade. [4] Macrophage activation syndrome (MAS) is a known, life-threatening disorder that may develop in people with rheumatic conditions, in particular Still's disease, and should be aggressively ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis.
Certolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, [4] [5] rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Ads
related to: tocilizumab prescribing information pdf